Invention Grant
- Patent Title: Methods and compositions involving NKG2D inhibitors and cancer
-
Application No.: US14343543Application Date: 2012-09-07
-
Publication No.: US10040853B2Publication Date: 2018-08-07
- Inventor: Thomas Spies , Veronika Spies
- Applicant: Thomas Spies , Veronika Spies
- Applicant Address: US WA Seattle
- Assignee: Fred Hutchinson Cancer Research Center
- Current Assignee: Fred Hutchinson Cancer Research Center
- Current Assignee Address: US WA Seattle
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2012/054214 WO 20120907
- International Announcement: WO2013/036799 WO 20130314
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K16/30 ; C07K16/28 ; A61K38/17 ; A61K31/7105 ; C12N15/113 ; A61K39/00
Abstract:
Embodiments methods and compositions involving inhibitors of the immunoreceptor Natural Killer Group 2, Member D, (NKG2D) for inhibiting tumor progression and treating cancer.
Public/Granted literature
- US20140377266A1 Methods and Compositions Involving NKG2D Inhibitors and Cancer Public/Granted day:2014-12-25
Information query
IPC分类:
